Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
Weinbergerova B, Mayer J, Kabut T, Hrabovsky S, Prochazkova J, Kral Z, Herout V, Pacasova R, Zdrazilova-Dubska L, Husa P, Bednar P, Ruzek D, Lengerova M. Weinbergerova B, et al. Among authors: zdrazilova dubska l. Hematol Oncol. 2021 Dec;39(5):715-720. doi: 10.1002/hon.2908. Epub 2021 Aug 16. Hematol Oncol. 2021. PMID: 34396566 Free PMC article. Clinical Trial. No abstract available.
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome.
Hlavackova E, Pilatova K, Cerna D, Selingerova I, Mudry P, Mazanek P, Fedorova L, Merhautova J, Jureckova L, Semerad L, Pacasova R, Flajsarova L, Souckova L, Demlova R, Sterba J, Valik D, Zdrazilova-Dubska L. Hlavackova E, et al. Front Oncol. 2019 Oct 25;9:1034. doi: 10.3389/fonc.2019.01034. eCollection 2019. Front Oncol. 2019. PMID: 31709173 Free PMC article.
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.
Pokorna P, Lakka Klement G, Vasikova A, Kanderova V, Jezova M, Noskova K, Mudry P, Kyr M, Merta T, Bajciova V, Krenova Z, Palova H, Valik D, Zdrazilova Dubska L, Slaby O, Sterba J. Pokorna P, et al. Among authors: zdrazilova dubska l. JCO Precis Oncol. 2022 Jun;6:e2100525. doi: 10.1200/PO.21.00525. JCO Precis Oncol. 2022. PMID: 35700412 Free PMC article. No abstract available.
Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.
Hacker UT, Hasenclever D, Baber R, Linder N, Busse H, Obermannova R, Zdrazilova-Dubska L, Valik D, Lordick F. Hacker UT, et al. Among authors: zdrazilova dubska l. Ann Oncol. 2022 Jul;33(7):685-692. doi: 10.1016/j.annonc.2022.03.274. Epub 2022 Apr 5. Ann Oncol. 2022. PMID: 35395383 Free article. Clinical Trial.
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA, Høgdall EV, Christensen IJ, Borgfeldt C, Kalapotharakos G, Zdrazilova-Dubska L, Chovanec J, Lok CA, Stiekema A, Mutz-Dehbalaie I, Rosenthal AN, Moore EK, Schodin BA, Sumpaico WW, Sundfeldt K, Kristjansdottir B, Zapardiel I, Høgdall CK. Karlsen MA, et al. Gynecol Oncol. 2015 Sep;138(3):640-6. doi: 10.1016/j.ygyno.2015.06.021. Epub 2015 Jun 16. Gynecol Oncol. 2015. PMID: 26086566
42 results